Cargando…
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902314/ https://www.ncbi.nlm.nih.gov/pubmed/36701008 http://dx.doi.org/10.1007/s00702-023-02591-z |
_version_ | 1784883232667336704 |
---|---|
author | Campagnolo, Marta Weis, Luca Fogliano, Carmelo Cianci, Valeria Garon, Michela Fiorenzato, Eleonora Carecchio, Miryam Ferreri, Florinda Bisiacchi, Patrizia Antonini, Angelo Biundo, Roberta |
author_facet | Campagnolo, Marta Weis, Luca Fogliano, Carmelo Cianci, Valeria Garon, Michela Fiorenzato, Eleonora Carecchio, Miryam Ferreri, Florinda Bisiacchi, Patrizia Antonini, Angelo Biundo, Roberta |
author_sort | Campagnolo, Marta |
collection | PubMed |
description | The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to describe clinical/cognitive and imaging features of a monocentric cohort of PSP patients, highlighting different patterns of functional disability according to the assigned phenotype. We retrospectively reviewed clinical/imaging data of 53 PSP patients diagnosed with probable PSP according to the MDS criteria and 40 age/sex-matched healthy controls (HCs). Neurological/neuropsychological assessments were performed using standardized scales, as well as comprehensive magnetic resonance imaging (MRI) morphometric measurements. In our cohort, there were 24/53 PSP-RS (Richardson’s syndrome), 13/53 PSP-P (Parkinsonism), 7/53 PSP-PGF (Progressive gait freezing), and 9/53 PSP-Cog (Cognitive impairment). PSP-Cog presented the worst motor profiles, the highest percentages of dementia and impaired functional autonomy; 4/9 PSP-Cog and 2/7 PSP-PGF died. PSP-P had the lowest motor/cognitive burden. All MRI parameters had good discriminative efficacy vs. HCs, with P/M 2.0 discriminating PSP-PGF from PSP-RS and PSP-Cog. We highlighted discrete clinical and imaging patterns that best characterize different PSP phenotypes. PSP-Cog and PSP-PGF/RS manifest greater incidence of dementia and motor disability, respectively, while PSP-P has a more benign course. The identification of different phenotypes may be the expression of different progression patterns requiring tailored approaches in terms of follow-up and treatment. These findings support the concept of discrete patterns of Tau pathology within the PSP spectrum and encourage research for phenotype-specific outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-023-02591-z. |
format | Online Article Text |
id | pubmed-9902314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-99023142023-02-08 Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes Campagnolo, Marta Weis, Luca Fogliano, Carmelo Cianci, Valeria Garon, Michela Fiorenzato, Eleonora Carecchio, Miryam Ferreri, Florinda Bisiacchi, Patrizia Antonini, Angelo Biundo, Roberta J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to describe clinical/cognitive and imaging features of a monocentric cohort of PSP patients, highlighting different patterns of functional disability according to the assigned phenotype. We retrospectively reviewed clinical/imaging data of 53 PSP patients diagnosed with probable PSP according to the MDS criteria and 40 age/sex-matched healthy controls (HCs). Neurological/neuropsychological assessments were performed using standardized scales, as well as comprehensive magnetic resonance imaging (MRI) morphometric measurements. In our cohort, there were 24/53 PSP-RS (Richardson’s syndrome), 13/53 PSP-P (Parkinsonism), 7/53 PSP-PGF (Progressive gait freezing), and 9/53 PSP-Cog (Cognitive impairment). PSP-Cog presented the worst motor profiles, the highest percentages of dementia and impaired functional autonomy; 4/9 PSP-Cog and 2/7 PSP-PGF died. PSP-P had the lowest motor/cognitive burden. All MRI parameters had good discriminative efficacy vs. HCs, with P/M 2.0 discriminating PSP-PGF from PSP-RS and PSP-Cog. We highlighted discrete clinical and imaging patterns that best characterize different PSP phenotypes. PSP-Cog and PSP-PGF/RS manifest greater incidence of dementia and motor disability, respectively, while PSP-P has a more benign course. The identification of different phenotypes may be the expression of different progression patterns requiring tailored approaches in terms of follow-up and treatment. These findings support the concept of discrete patterns of Tau pathology within the PSP spectrum and encourage research for phenotype-specific outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-023-02591-z. Springer Vienna 2023-01-26 2023 /pmc/articles/PMC9902314/ /pubmed/36701008 http://dx.doi.org/10.1007/s00702-023-02591-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Neurology and Preclinical Neurological Studies - Original Article Campagnolo, Marta Weis, Luca Fogliano, Carmelo Cianci, Valeria Garon, Michela Fiorenzato, Eleonora Carecchio, Miryam Ferreri, Florinda Bisiacchi, Patrizia Antonini, Angelo Biundo, Roberta Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title | Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title_full | Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title_fullStr | Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title_full_unstemmed | Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title_short | Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
title_sort | clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes |
topic | Neurology and Preclinical Neurological Studies - Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902314/ https://www.ncbi.nlm.nih.gov/pubmed/36701008 http://dx.doi.org/10.1007/s00702-023-02591-z |
work_keys_str_mv | AT campagnolomarta clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT weisluca clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT foglianocarmelo clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT ciancivaleria clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT garonmichela clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT fiorenzatoeleonora clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT carecchiomiryam clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT ferreriflorinda clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT bisiacchipatrizia clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT antoniniangelo clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes AT biundoroberta clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes |